I wanted to take this opportunity to catch everyone up on the latest developments with the foundation. Our fund raising event at Harvard University was a tremendous success. The event was well attended and provided a great deal of benefit to everyone involved. We are looking forward to future endeavors to be held in Cambridge and are thankful for our partnership with Team AJ, some of the best people I have ever worked with.
Last year Dr. Patrick Aubourg in Paris introduced findings related to a gene therapy protocol he recently completed. This therapy used bone marrow from two ALD positive boys, their own marrow. Once extracted, the stemm cells were seperated from the marrow. They were then put through a gene therapy wash, attached to a vector, and redelivered into their bodies. My understanding is that to date, the process of ALD has been halted in both boys. As more information becomes available, I will keep all well informed.
Lastly, we are looking forward to the development of new therapies in 2008. It looks to be a tremendous year and we all hope and pray that it will be a time for solutions.
Thanks to everyone for all of your support!
David A. Cry
Chief Executive Officer
The Adrenoleukodystrophy Foundation